ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
105,012.07
0.27%
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs Yen
155.995
0.00%
Brent Oil
77.625
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX

  6. Channel Therapeutics Corporation (CHRO) 銘柄情報

Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

AMEX
2.44
-0.35
(-12.54%)
終了 1月26日 6:00AM
15分遅延
2.43
-0.01
(-0.41%)
取引時間後: 9:58AM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
2.43
買値
-
売値
-
出来高
243,615
2.30 日の範囲 2.86
0.45 52 週間の範囲 6.00
時価総額
14.648M
前日終値
2.79
始値
2.81
時刻
4942
@
2.44
最終取引時間
財務取引量
US$ 629,452
VWAP
2.5838
平均取引量 (3 か月)
977,826
発行済株式数
6,028,011
配当利回り
-
PER
-2.00
1 株当たり利益 (EPS)
-1.22
歳入
-
純利益
-7.38M

Channel Therapeutics Corporation について

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
channeltherapeutics.com
本社
Reno, Nevada, USA
設立
-
Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the アメリカ証券取引所 with ticker CHRO. The last closing price for Channel Therapeutics was US$2.79. Over the last year, Channel Therapeutics shares have traded in a share price range of US$ 0.45 to US$ 6.00.

Channel Therapeutics currently has 6,028,011 shares in issue. The market capitalisation of Channel Therapeutics is US$16.82 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -2.00.

CHRO 最新ニュース

その他のニュース

Chromocell Announces Amendment to Stock Repurchase Plan

FREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

2024年10月24日
GlobeNewswire Inc.

Chromocell to Participate in the Virtual Investor Lunch Break Series

FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

2024年7月15日
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

2024年6月19日
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

2024年5月16日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年5月16日
Edgar (US Regulatory)

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

FREEHOLD, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

2024年5月13日
GlobeNewswire Inc.

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

2024年4月9日
GlobeNewswire Inc.

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

2024年3月21日
GlobeNewswire Inc.

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

2024年3月18日
GlobeNewswire Inc.

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...

2024年3月11日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
11.34122.9357798171.093.81157537832.432464CS
41.75257.3529411760.683.80.60130612202.37776582CS
121.81291.9354838710.623.80.459778262.25533944CS
261.08801.353.80.454901362.05698303CS
52-3.57-59.5660.452753802.06986619CS
156-3.57-59.5660.452753802.06986619CS
260-3.57-59.5660.452753802.06986619CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?
The current share price of Channel Therapeutics is US$ 2.43
How many Channel Therapeutics shares are in issue?
Channel Therapeutics has 6,028,011 shares in issue
What is the market cap of Channel Therapeutics?
The market capitalisation of Channel Therapeutics is USD 16.82M
What is the 1 year trading range for Channel Therapeutics share price?
Channel Therapeutics has traded in the range of US$ 0.45 to US$ 6.00 during the past year
What is the PE ratio of Channel Therapeutics?
The price to earnings ratio of Channel Therapeutics is -2
What is the reporting currency for Channel Therapeutics?
Channel Therapeutics reports financial results in USD
What is the latest annual profit for Channel Therapeutics?
The latest annual profit of Channel Therapeutics is USD -7.38M
What is the registered address of Channel Therapeutics?
The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the Channel Therapeutics website address?
The website address for Channel Therapeutics is channeltherapeutics.com
Which industry sector does Channel Therapeutics operate in?
Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
DXFEason Technology Limited
 29.30
(33,044.80%)
466.04k
AXILAXIL Brands Inc
US$ 6.60
(39.01%)
75.83k
EXODExodus Movement Inc
US$ 61.00
(38.64%)
198.35k
AMBOAmbow Education Holding Ltd
US$ 2.324
(22.32%)
61.87k
NVOXDefiance Daily Target 2x Long Nvo ETF
US$ 11.94
(16.60%)
221.49k
TPETTrio Petroleum Corp
US$ 1.555
(-22.64%)
2.66M
TOPPToppoint Holdings Inc
US$ 3.0953
(-16.20%)
119.3k
CHROChannel Therapeutics Corporation
US$ 2.45
(-12.19%)
243.62k
BURUNuburu Inc
US$ 0.385
(-10.59%)
2.66M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 10.44
(-10.46%)
45.22M
BTGB2Gold Corp
US$ 2.40
(2.13%)
76M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 32.65
(-6.50%)
59.85M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 2.83
(5.99%)
59.26M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 10.44
(-10.46%)
45.22M
FXIiShares China Large Cap
US$ 31.32
(2.49%)
45.11M

CHRO Discussion

投稿を表示

最近閲覧した銘柄

AMEX
CHRO
Channel Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有